Bioelectronic devices link microbes and materials to convert chemical signals into electrical outputs for sensing, energy, and synthesis. Unlocking this potential requires systems that can interrogate electroactive cells rapidly and at scale, but traditional bioelectrochemical platforms remain costly, bulky, and low throughput.
The increasing demand for real-time, wireless, and sustainable motion monitoring in applications such as personal health, professional sports, and human-machine interactions calls for wearable devices that are lightweight and battery free.
SAN DIEGO, Nov. 3, 2025 /PRNewswire/ — The U.S. Food and Drug Administration (“FDA”) has granted QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global leader of in vitro diagnostics, 510(k) clearance for the VITROS hs Troponin I Reagent Pack (the “VITROS hs Troponin I Assay”). The assay is intended for the quantitative measurement of cardiac troponin I (cTnI) in human plasma (heparin) to aid in the diagnosis of myocardial infarction (MI).
VANCOUVER, BC, Nov. 3, 2025 /PRNewswire/ — WAT Medical Enterprise Ltd. proudly announced the publication of a groundbreaking clinical trial in The Journal of Bone & Joint Surgery (JBJS) which demonstrates the significant benefits of the EmeTerm wristband in reducing postoperative nausea and vomiting (PONV) in patients undergoing total hip or knee arthroplasty (THA/TKA) under spinal anesthesia.
University of Texas at Dallas researchers have developed biosensor technology that, when combined with artificial intelligence (AI), shows promise for detecting lung cancer through breath analysis.
A naturally occurring gene called Cyclin A2 (CCNA2), which turns off after birth in humans, can actually make new, functioning heart cells and help the heart repair itself from injury, including a heart attack or heart failure, when the gene is turned back on.
Cornell University researchers and collaborators have developed a neural implant so small that it can rest on a grain of salt, yet it can wirelessly transmit brain activity data in a living animal for more than a year.
MIT researchers show they can use messenger RNA to activate the pathway and trigger the immune system to attack tumors.
Antibody unmasks pancreatic tumors’ ‘sugar-coated’ disguise to keep them from evading immune system
InterVene’s Recana is claimed to be the first fully integrated catheter system to address venous in-stent restenosis (ISR).